Applied DNA Awarded U.S. Patents on SigNature® T Molecular Tag and Multimode Reader Authentication Device
November 03 2017 - 5:30AM
Business Wire
New patents protect SigNature T molecular
tagging technology and a multimode reader device enabling IT
integrated instant authentication
Applied DNA Sciences, Inc. (“Applied DNA,” “the Company,”
NASDAQ: APDN) is pleased to announce the issuance of U.S. Patent
No. 9,790,538 (US 2014/0256881) entitled “Alkaline Activation for
Immobilization of DNA Taggants” and a Notice of Allowance of U.S.
Patent Application 15/027,454 (US 2016/0246892) entitled “Multimode
Image and Spectral Reader.”
The ‘538 patent, issued on October 17, 2017, protects the core
technology powering Applied DNA’s SigNature T molecular tags in the
textile industry and is directed at methods of enhancing the
binding affinity of molecular tags to a variety of textile
substrates, including cotton, wool, cellulosic materials and
man-made fibers. The enhanced binding affinity of the SigNature T
molecular tags enables them to survive extremely harsh
manufacturing processes, such as those found in leather, cotton and
synthetics manufacturing. The patented methods are currently used
in wide range of SigNature T applications, and are integral to the
Company’s pursuit of a global textile industry anticipated to grow
to $910 billion in sales in 2019 from $750 billion in 2015*.
The ‘454 Application, allowed on October 26, 2017 will issue as
a patent, and protects Applied DNA’s proprietary Multimode Image
and Spectral Reader (“MMR”) device that provides for instant
detection and identification of a wide variety of optical,
molecular, olfactory and radio based taggants through the use of
electronic sensor capture and digital database analysis. The
handheld MMR device can rapidly detect one or more taggants and
compare the detected taggants to library of known taggant
configurations to provide instant authentication.
“We take great pride in the patenting of our SigNature T
molecular tags, providing us with broad long-term market
exclusivity. In addition, the patenting of our MMR device paves the
way for the instant authentication of a broad range of taggants and
exciting licensing opportunities,” said Dr. James Hayward,
president and CEO of Applied DNA. “Protecting our innovations has
always been a cornerstone of Applied DNA. Our robust intellectual
property portfolio is more important than ever, as industry
awareness and acceptance of our technologies is rapidly
growing.”
The issuance of the ‘538 patent raises Applied DNA’s patent
portfolio to 53, in addition to over 70 pending applications.
*Work Textile Information Network’s ‘World Textile Outlook 2016’
(click for free report).
To learn more about Applied DNA visit www.adnas.com.
About Applied DNA
Sciences
Applied DNA is a provider of molecular technologies that enable
supply chain security, anti-counterfeiting and anti-theft
technology, product genotyping and DNA mass production for
diagnostics and therapeutics.
We make life real and safe by providing innovative,
molecular-based technology solutions and services that can help
protect products, brands, entire supply chains, and intellectual
property of companies, governments and consumers from theft,
counterfeiting, fraud and diversion. The proprietary DNA-based
“CertainT®” platform can be used to identify, tag, test, and track
products, to help assure authenticity, origin, traceability,
sustainability and quality of products.
SigNature® DNA describes the core technology ingredient that is
at the heart of a family of uncopyable, security and authentication
solutions such as SigNature®T and fiberTyping®, targeted towards
textiles and apparel, BackTrac™ and DNAnet®, for anti-theft and
loss prevention, and digitalDNA®, providing powerful
track-and-trace. All provide a forensic chain of evidence, and can
be used to prosecute perpetrators. Applied DNA Sciences is also
engaged in the large-scale production of specific DNA sequences
using the polymerase chain reaction.
Visit adnas.com for more information. Follow us
on Twitter and LinkedIn. Join our mailing
list.
Forward-Looking
Statements
The statements made by APDN in this press release may be
“forward-looking” in nature within the meaning of the Private
Securities Litigation Act of 1995. Forward-looking statements
describe APDN’s future plans, projections, strategies and
expectations, and are based on assumptions and involve a number of
risks and uncertainties, many of which are beyond the control of
APDN. Actual results could differ materially from those projected
due to our short operating history, limited financial resources,
limited market acceptance, market competition and various other
factors detailed from time to time in APDN’s SEC reports and
filings, including our Annual Report on Form 10-K filed on December
6, 2016, and our subsequent quarterly reports on Form 10-Q filed on
February 9, 2017, May 11, 2017 and August 10, 2017 which are
available at www.sec.gov. APDN undertakes no obligation to
update publicly any forward-looking statements to reflect new
information, events or circumstances after the date hereof to
reflect the occurrence of unanticipated events, unless otherwise
required by law.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171103005105/en/
For Applied DNA Sciences, Inc.Investors:Sanjay Hurry,
212-838-3777shurry@lhai.comorMedia:Angie Mathews,
781-639-4924angie@cgprpublicrelations.comorProgram:MeiLin
Wan,
631-240-8849meilin.wan@adnas.comorWeb: www.adnas.comTwitter:
@APDN
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Apr 2023 to Apr 2024